Tilray Jumps on U.S. Study of Cannabis in Breast Cancer Patients

Cannabis Culture
By Gregory Calderone, Bloomberg NewsOct 24, 2019, 8:46 pm213 pts
Tilray Inc. shares jumped as much as 14 per cent after announcing it successfully imported medical cannabis into the U.S. in support of a clinical trial studying its efficacy in treating patients with disorders caused by breast cancer treatments. The study will focus on patients suffering from taxane-induced…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Collective Project Launches Portfolio of Hemp-Derived THC Beverages in 25 States 69

DEA Provides No Cannabis Rescheduling Update After 180 Days 69

Nature’s Heritage Brings Old-School Genetics to the Modern Market 68

4 Pitfalls to Avoid When Seeking a Cannabis Trademark (and Tips to Avoid Them) 68

Oregon Police Improperly Used Aerial Camera To Bust Marijuana Grow, State Appeals Court Says 68

Built to Withstand: 5 Adaptations Cannabis Facilities Should Make for Corrosion Resistance 62

FLUENT Opens Company’s 1st Adult-Use Dispensary in New York 27

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.